When a new drug enters the market, it brings with it both hope and uncertainty. Clinical trials, despite their scientific rigor, are limited in scope — they can’t predict how a drug will behave in real-world conditions, across varied patient…
In the pharmaceutical world, Adverse Drug Reactions (ADRs) are not just unfortunate events — they’re regulatory red flags, patient safety threats, and potential business disasters. Why is this so critical? Because a single overlooked ADR can lead to product…
Regulations in the pharmaceutical sector are dynamic, evolving to keep pace with new products and technologies. The Central Drugs Standard Control Organization (CDSCO), Government of India, continually updates its rules to ensure drug quality, safety, and efficacy. A significant development…
Recent Post
- India brings Pregabalin under Schedule H1
- CDSCO Issues Stern Warning Against Injectable Cosmetics and Misleading Beauty Claims
- CDSCO Orders Nationwide Crackdown on Unauthorised GLP-1 Weight Loss Drugs
- Drug Applications with Unanswered Queries to Be Rejected Within 30 Days by CDSCO
- ⚖️ “No Approval, No Market”: Delhi High Court Sends a Strong Message on Unapproved Drugs & FDCs
